HGHTX Mutual Fund

HGHTX Mutual Fund

NAV$56.22
See how much of HGHTX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$1M
Expense Ratio
1.04%
Dividend Yield (Current)
-
Holdings
83
Inception Date
Dec 22, 2006
Fund Family
Hartford Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+15.01%
1 Year+25.48%
3 Year+14.75%
5 Year+4.54%
10 Year+10.62%

Asset Allocation

Stocks: 99.79%
Other: 0.21%
See how much of HGHTX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co11.62%
JNJJohnson & Johnson - Common6.71%
MRKMerck & Company Inc6.42%
ABBVAbbvie Inc.4.33%
UNHUnitedhealth Group Incorporated4.27%
Top 10 Concentration: 47.14%Report Date: Aug 31, 2026
Download all 83 holdings for HGHTX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

HGHTX Mutual Fund Overview

HGHTX Mutual Fund (The Hartford Healthcare Fund Cl R5) is managed by Hartford Funds with $1.1M in net assets. HGHTX expense ratio is 1.04%, holding 83 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2006-12-22.

HGHTX performance shows a YTD return of 15.01%. The 1-year return is 25.48% and the 5-year return is 4.54%.

HGHTX top holdings include Eli Lilly & Co (11.6%), Johnson & Johnson - Common (6.7%), Merck & Company Inc (6.4%), Abbvie Inc. (4.3%), Unitedhealth Group Incorporated (4.3%). Go to all HGHTX holdings, HGHTX sectors, or HGHTX dividends.

HGHTX can be compared against other funds. Use HGHTX overlap to find shared positions, or HGHTX vs another fund for a side-by-side view. HGHTX alternatives are available via the screener, along with tax-loss harvesting opportunities.